pharmacogenomics
| 4 min read
A newly certified DPYD genotyping assay gives oncologists a validated way to flag chemotherapy toxicity risk before treatment starts
| 2 min read
New recombinant enzyme kits set to improve personalized drug development and reduce adverse reactions in diverse patient groups.
Available on Demand
Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief.
Page 1 of 1 - 3 Total Items
